News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
SSY GROUP (02005.HK) Vitamin B12 Injection Passes Consistency Evaluation
SSY GROUP (02005.HK) announced that its Vitamin B12 Injection has obtained approval from the National Medical Products Administration for an additional 1ml: 1mg specification, and ...
Reset
Send
The window will close in 5 seconds
SSY GROUP (02005.HK) Vitamin B12 Injection Passes Consistency Evaluation
Close
Recommend
1
Positive
1
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

SSY GROUP (02005.HK)  +0.070 (+3.097%)    Short selling $8.86M; Ratio 43.687%   announced that its Vitamin B12 Injection has obtained approval from the National Medical Products Administration for an additional 1ml: 1mg specification, and has also been approved as having passed the consistency evaluation for the quality and efficacy of generic drugs, becoming the second domestic enterprise to achieve this.

Vitamin B12 Injection is mainly used for the treatment of megaloblastic anemia caused by intrinsic factor deficiency, and can also be used as an adjunctive therapy for subacute combined degeneration of the nervous system, such as neuritis. (ha/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-29 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.